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Abstract
Identifying new target molecules through which eosinophils secrete their stored proteins
may reveal new therapeutic approaches for the control of eosinophilic disorders such as
host immune responses to parasites. We have recently reported the expression of the puri-
nergic P2Y12 receptor (P2Y12R) in human eosinophils; however, its functional role in this
cell type and its involvement in eosinophilic inflammation remain unknown. Here, we investi-
gated functional roles of P2Y12R in isolated human eosinophils and in a murine model of
eosinophilic inflammation induced by Schistosoma mansoni (S.mansoni) infection. We
found that adenosine 5’-diphosphate (ADP) induced human eosinophils to secrete eosino-
phil peroxidase (EPO) in a P2Y12R dependent manner. However, ADP did not interfere
with human eosinophil apoptosis or chemotaxis in vitro. In vivo, C57Bl/6 mice were infected
with cercariae of the Belo Horizonte strain of S.mansoni. Analyses performed 55 days post
infection revealed that P2Y12R blockade reduced the granulomatous hepatic area and the
eosinophilic infiltrate, collagen deposition and IL-13/IL-4 production in the liver without
affecting the parasite oviposition. As found for humans, murine eosinophils also express the
P2Y12R. P2Y12R inhibition increased blood eosinophilia, whereas it decreased the bone
marrow eosinophil count. Our results suggest that P2Y12R has an important role in eosino-
phil EPO secretion and in establishing the inflammatory response in the course of a S. man-
soni infection.
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Introduction
Parasitic helminth infections, which are prominent agents of disease in resource-limited
regions, are the most common cause of persistent eosinophilia, a prominent feature of immune
responses to Schistosoma mansoni (S.mansoni) [1]. Eosinophils are leukocytes that contain an
abundance of large cytoplasmic granules that are ultrastructurally unique due to their internal
crystalline cores. These granules store a variety of preformed proteins, including four cationic
proteins, eosinophil cationic protein (ECP), major basic protein (MBP), eosinophil peroxidase
(EPO), and eosinophil-derived neurotoxin protein (EDN); hydrolytic enzymes; and more than
three dozen cytokines (including IL-13, IL-4, IL-5, IL-10, IL-6, TNF-α and IFN-γ), chemokines
and growth factors that can be rapidly mobilized and released extracellularly [1, 2]. More than
two billion people are infected with parasitic helminths worldwide [3]. Although infections by
these pathogens are generally not fatal, they are associated with high rates of morbidity [3].
Infections with S.mansoni cause dramatic increases in eosinophilopoiesis, in the levels of
eosinophils in peripheral blood and in the granulomas induced in the host tissues by parasite
eggs [4]. The morbidity due to S.mansoni infections arises from the granulomatous, immune-
mediated response to eggs that become trapped in the host liver and gut after being released by
fecund females residing in the mesenteric venous plexus [4]. Eosinophils have long been tradi-
tionally thought to function solely as terminal effector cells in Th2 immune responses, includ-
ing exerting helminthotoxic activity against parasites. Eosinophils can kill schistosomula in
vitro in the presence of antibody and/or complement [5]. However, the function(s) of eosino-
phils in parasitic infections in vivo remains poorly understood. In vivo, eosinophils have the
capacity to invade dying schistosomes [6], suggesting that they might be an important defense
mechanism against the parasite. Eosinophils are also responsible for a considerable amount of
the inflammatory pathology accompanying helminth infections. Similarities between the
sequelae of hypereosinophilic syndromes, which are syndromes characterized by extremely
high levels of eosinophilia [7], and the pathologic consequences of helminth infection suggest a
potential role for eosinophils in the immunopathogenesis of these infections. Eosinophils can
damage both parasites and their surrounding tissues through a number of different mecha-
nisms, including reactive oxygen species (ROS) generation, release of eosinophil cationic pro-
teins and lipid mediators, such as leukotrienes [8]. However, two different mouse lineages
genetically deficient in eosinophils exhibited no prominent alterations in worm burdens or
granuloma formation during experimental S.mansoni infections [9], suggesting that eosino-
phils do not simply function as helminthotoxic killer cells or pro-inflammatory cells. Data col-
lected over the years are beginning to reveal more complex roles for eosinophils, including a
more dynamic picture of Th2 immunity, where eosinophils are present very early in the
response to Th2-inducing agents and function as antigen-presenting cells contributing to the
initiation of Th2 immunity [10]. Recently, we identified the secretion competence of cytolyti-
cally released cell-free eosinophil granules (as found in the lesions around helminths) that,
once deposited extracellularly in tissues, might themselves enhance Th2 immune responses in
the absence of intact eosinophils [11–13].
Purinergic P2 receptors are expressed in many tissues and organs and are activated by extra-
cellular nucleotides, such as adenosine triphosphate (ATP), adenosine diphosphate (ADP), uri-
dine 5’-diphosphate (UDP) and uridine 5’-triphosphate (UTP), which are released as a
consequence of cell damage, cell stress, bacterial infection or other noxious stimuli. After tissue
injury, intracellular nucleotides can be released into the extracellular environment, acting as
proinflammatory endogenous signaling molecules (danger-associated molecular pattern–
DAMPs—or alarmins) capable of functioning as both chemoattractants and activation signals
for immune cells [14, 15]. According to their molecular structure, P2 receptors are divided into
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2 subfamilies–P2X and P2Y receptors. The P2X receptors are ligand-gated channels, whereas
P2Y receptors are G- protein-coupled, seven-membrane-spanning receptors. Several studies
indicate that nucleotides play an important role in immune response modulation through their
action on multiple cell types, including monocytes, mast cells, dendritic cells, neutrophils and
eosinophils [15–17]. Human eosinophils express several mRNAs that encode P2X and P2Y
purinergic receptor subtypes, P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y14, P2X1, P2X4 and P2X7;
however, the activation of these purinergic receptors and their capacities to mediate different
eosinophil responses are not fully known [18]. We have recently reported the expression of the
P2Y12 receptor (P2Y12R) on human eosinophils and cell-free human eosinophil granules [12].
However, the functional roles of P2Y12R and its contributions to eosinophilic inflammation
and host defense remain to be elucidated. P2Y12R is a Gi/o coupled receptor that is classically
responsive to ADP. The key roles for ADP and its receptors in vascular biology and platelet
aggregation in vivo are well established by studies with P2Y1 and P2Y12 receptor-null mice
and are validated in humans by the clinical efficacy of P2Y12 antagonists (e.g., clopidogrel) as
antiplatelet agents [19]. Recently, P2Y12R was identified as a receptor sensitive to leukotriene
E4 (LTE4) playing a prominent role in the mediation of LTE4–induced pulmonary inflamma-
tion [20]. Thus, modulation of P2Y12R might represent a new strategy to control eosinophil
activation and degranulation in eosinophilic pathological conditions. The goal of this study is
to investigate whether P2Y12R has functional roles in eosinophil activation and in the inflam-
matory host immune response induced by S.mansoni infection.
Materials and Methods
Ethics statement
All protocols and experimental procedures involving animals were approved by the Committee
for Ethics in Animal Experimentation (CEUA) at Federal University of Rio de Janeiro (license
number DFBCICB 043). Mice were sacrificed by anesthesia (pentobarbital, 40 mg/kg and xyla-
zine, 2.5 mg/kg, intramuscularly) followed by cervical dislocation. All efforts were made to
minimize suffering during the procedures in this project. All animal experiments were con-
ducted in accordance with Brazilian Federal Law number 11.794, which regulates the scientific
use of animals, and IACUC guidelines. Human peripheral blood for eosinophil purification
was obtained with written informed consent from healthy donors under protocols approved by
the Clementino Fraga Filho Hospital Ethical Committee (Federal University of Rio de Janeiro)
(license number 190/09).
Eosinophil purification and stimulation
Eosinophils were purified from the blood of healthy donors as previously described [11]. The
viability and purity of freshly isolated eosinophils were>99% as analyzed by trypan blue exclu-
sion and Panoptic kit staining, respectively. (250,000/250 μL) were resuspended in RPMI 1640
plus 0.1% ovalbumin (without phenol red) (Sigma, St. Louis, MO, USA) and stimulated with
ADP (0.1–100 nM) (Sigma, St. Louis, MO, USA). Treatments with MRS2395 (10 μM) (Sigma,
St. Louis, MO, USA), a selective P2Y12R antagonist, or with MRS2179 (10 μM) (Sigma,
St. Louis, MO, USA), a selective P2Y1R antagonist, were performed for 15 min prior to stimu-
lation with ADP (100 nM) for 1 h at 37°C. Thereafter, supernatants were collected and stored
at −20°C for further EPO quantification. Drugs were diluted in DMSO at a final concentration
of<0.01%, which had no effect on eosinophil secretion.
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Assay of eosinophil-secreted EPO
EPO activity was measured in the supernatants using a colorimetric assay [21]. Briefly, 20 μL
of the supernatants were incubated with 100 μL substrate solution (50 mM Tris-HCl, 1 mM
H2O2, 2 mM O-phenylenediamine dihydrochloride (OPD) (Sigma, St. Louis, MO, USA) and
0.1% Triton X-100, pH = 8). The reaction was stopped after 30 minutes of incubation by the
addition of 100 μL 4 M H2SO4. The plate was read at 492 nm.
Bone marrow derived eosinophils
With slight modifications, eosinophils were differentiated in vitro from mouse bone marrow
cells, as previously described [22]. Briefly, bone marrow cells were collected from femurs and
tibiae of wild-type BALB/c mice with RPMI 1640 (Sigma-Aldrich, St. Louis, MO, USA) without
FBS. After red blood cell lysis, cells were cultured at 106 cells/ml in RPMI 1640 containing 20%
FBS (VitroCell, Campinas, SP, Brazil), 100 IU/ml penicillin, 10 μg/ml streptomycin, 2 mM glu-
tamine (Sigma-Aldrich, St. Louis, MO, USA), 1 mM sodium pyruvate (Sigma-Aldrich,
St. Louis, MO, USA), 1% non essential amino acid solution (MEN) (Sigma-Aldrich, St. Louis,
MO, USA), 100 ng/ml stem cell factor (PeproTech, NJ, USA), and 100 ng/ml FLT3 ligand
(PeproTech, NJ, USA) from days 0 to 4. On day 4, the stem cell factor and FLT3 ligand were
replaced by IL-5 (10 ng/ml; Peprotech, NJ, USA). On day 14, eosinophils were enumerated and
labeled for flow studies.
Flow cytometry of eosinophils
Human or bone marrow derived eosinophils were fixed in 4% paraformaldehyde (PFO) and
permeabilized for 5 min on ice with 0.1% saponin (Sigma, St. Louis, MO, USA) before incuba-
tion with the primary antibody (Ab), control Ab or primary Ab premixed with the blocking
peptide (1 h). Next, the cells were washed and incubated with the respective FITC-conjugated
secondary Abs for 15 min on ice in the continued presence of saponin. After staining, the
eosinophils were fixed in a buffer containing 4% paraformaldehyde (PFO). Analyses were per-
formed on a FACScan with CELLQUEST software (BD Biosciences, CA, USA). For labeling,
rat anti-Siglec-F phycoerythrin(PE)-conjugated antibody (1:100, BD Pharmingen, CA, USA;
Siglec-F is a murine eosinophil marker), rabbit anti-P2Y12R polyclonal Ab (1:100, Alomone
Labs, Jerusalem, Israel) (directed against the carboxy-terminal intracelullar domain of the
receptor) or the anti-P2Y12R Ab premixed with the blocking peptide were used. Anti-rabbit
Ab conjugated to fluorescein (FITC) (1:500, Jackson ImmunoResearch, PA, USA) was used as
a secondary Ab.
Fluorescence Microscopy
Eosinophils were stained as described for flow cytometry. Subsequently, cells were incubated
with DAPI (1 μg/ml) and coverslipped. In a different set of experiments, murine eosinophil-
enriched suspensions were cytocentrifuged and fixed in a buffer containing 4% PFO. Thus,
cells were permeabilized for 5 min with 0.1% saponin (Sigma, St. Louis, MO, USA) before the
incubation with rabbit anti-P2Y12R polyclonal Ab or the primary Ab premixed with the block-
ing peptide (1:100, Alomone Labs, Jerusalem, Israel) (directed against the carboxy-terminal
intracelullar domain of the receptor) and with the rat anti-Siglec-F phycoerythrin(PE)-conju-
gated antibody (1:100, BD Pharmingen, CA, USA; Siglec-F is a murine eosinophil marker).
Anti-rabbit Ab conjugated to fluorescein (FITC) (1:500, Jackson ImmunoResearch, PA, USA)
was used as a secondary Ab. Control or nonimmune Abs were included for all. Fluorescence
P2Y12R in Eosinophils and Anthelmintic Host Response
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images were acquired using an Olympus DP72 camera coupled to a BX-53 Olympus micro-
scope (Olympus, Center Valley, PA, USA).
Detection of apoptotic cells
Classic annexin V labeling was used. Eosinophils were cultured in the presence of recombinant
human IL-5 (30 ng/ml) (positive control) or ADP (10–100 nM) or MRS2395 (10 μM) for 24 h,
followed by the addition of FITC-labeled annexin V (an early apoptosis marker) (1 μg/mL, Bio-
vision, Mountain View, CA). The cells were incubated for 15 min on ice and immediately ana-
lyzed on the flow cytometer (BD Accuri C6, BD Biosciences).
Eosinophil migration assay
Human eosinophils were resuspended in RPMI 1640 plus 0.1% ovalbumin and added (3x105
cells in 100 μL) in duplicate to the upper chambers of 24-well transwell plates (Corning Glass,
Corning, MA, USA) with a 5 μm pore size. ADP (100 and 10 nM) or eotaxin (20 ng/mL) were
diluted in 600 μL RPMI 1640 plus 0.1% ovalbumin medium and placed in the lower chambers
of the transwell plates. In a different set of experiments, the eosinophils were pre-treated with
the compound MRS2395 (a P2Y12R antagonist) or its diluent (DMSO) at 37°C for 15 min or
primed for 2 h at 37°C with IL-5 (30 ng/mL) before the transwell system was assembled. The
plates were incubated for 3 h at 37°C before recovering, and migrating cells from the lower
compartment were counted. The cells were quantitated from duplicate wells by averaging the
total events counted in 100 μL using a flow cytometer (BD Accuri C6 –counter mode, BD
Biosciences).
Animals and S.mansoni infection
C57Bl/6 mice (8 weeks) were percutaneously infected with 60 cercariae of the Belo Horizonte
(BH) strain of S.mansoni. Animals from all groups were sacrificed under anesthesia followed
by cervical dislocation after 55 days of infection. Two schistosome independent infection stud-
ies were performed with at least 5 animals/each group.
Parasitological parameters
Hepatic and intestinal tissues were maintained in 4% KOH at room temperature for 12 h, fol-
lowed by 1 h of incubation at 37°C. The results were expressed as the number of eggs per gram
of tissue. Counts were performed in triplicate using light microscopy (100x).
Histopathology and morphometric analysis
Tissue samples were fixed in 10% buffered formalin and embedded in paraffin. Five-microme-
ter sections were stained with hematoxylin-eosin or Llewellyn’s Sirus Red (Direct Red 80, CI
35780; Aldrich, Milwaukee, WI) for better eosinophil visualization. Quantitative analysis of the
tissue sections and of captured images was carried out using a computer-assisted image ana-
lyzer (Scion Image version 4.0.3.2, Scion Corp). All evaluations were performed by two differ-
ent blinded observers. The area of hepatic granuloma was determined in histological sections
from 20 to 30 granulomas per animal, containing central eggs, randomly chosen. Digital photo-
graphs were obtained under light microscopy at 400x magnification. To estimate the size of
granulomas, we measured their individual areas using the measurement tool of the image ana-
lyzer. Eosinophil infiltrates were identified in the granuloma area and expressed as eosinophils/
unit area (μm2).
P2Y12R in Eosinophils and Anthelmintic Host Response
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Quantification of cytokines
Cytokine concentrations (IL-4 and IL-13) in the hepatic tissue and plasma were measured
using a sandwich enzyme-linked immunosorbent assay technique (ELISA) with capture and
detection antibodies according to the instructions of the manufacturer (Peprotech, NJ, USA).
Hydroxyproline quantification
Hepatic and intestinal tissues were digested as described by Cheever [23]. Livers were main-
tained in acetone at room temperature until complete dehydration, followed by hydrochloric
acid hydrolyzation for overnight incubation at 107°C. Colorimetric assay was then performed
using chloramine-T buffer (Sigma, USA), Ehrlich's reagent (Sigma, USA), and perchloric acid
(Merck).
Blood and bone marrow eosinophilia
Blood eosinophilia was analyzed by light microscopy of blood smears after Panoptic kit stain-
ing. To evaluate bone marrow eosinophilia, mice were killed and the femurs removed. The
bone marrow cavity was flushed with RPMI 1640 (Sigma, St. Louis, MO). The cells were cyto-
centrifuged and counted under light microscopy after Panoptic kit staining.
Murine eosinophil-enriched suspensions
Livers from S.mansoni-infected mice were homogenized, and intact granulomas were allowed
to sediment. After multiple washes with RPMI 1640 medium, granulomas were transferred to
culture bottles and left overnight 37°C in CO2 incubator. Eosinophils remain in suspension
while other cells (like macrophages) attach to the bottle. After that, medium was collected and
centrifuged. Pellets were suspended in medium and cells were counted. The cells were cytocen-
trifuged and counted under light microscopy after Panoptic kit staining or anti-Siglec-F stain-
ing (Siglec-F is a murine eosinophil marker) to determine the percentage of eosinophils in
suspension. The nonadherent fraction was composed by 50% eosinophils.
Tail bleeding test
The tail bleeding test was performed in accordance with Broze and colleagues [24]. After 23
days of clopidogrel treatment, the mice were anesthetized (pentobarbital, 40 mg/kg and xyla-
zine, 2.5 mg/kg, intramuscularly). Several minutes later, the mice were immobilized in a
restraint device and had the tail cut 4 mm from the tip and immersed in 5 mL of distilled water
at room temperature. The shed blood was evaluated as a function of the absorbance at 540 nm
due to the hemoglobin content in the water solution. The concentration of hemoglobin was
measured spectrophotometrically using a microplate spectrophotometer at 540 nm (Molecular
Probes). The mice were then carefully observed for the next 6 h and checked the next morning
for signs of delayed bleeding.
Statistical analysis
Statistical analysis was performed with Prism software (GraphPad Software, Inc., San Diego,
CA, USA). Results were analyzed by one-way ANOVA, followed by the Newman-Keuls test or
by Student’s t test. Values are expressed as the mean ± standard error (SE). P values< 0.05
were considered significant.
P2Y12R in Eosinophils and Anthelmintic Host Response
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Results
P2Y12Rmediates ADP-induced eosinophil peroxidase (EPO) secretion
in human eosinophils
In a previous study, we characterized the expression of P2Y12R on human eosinophils [12]. In
this study, we first conducted a series of experiments to confirm these findings. As shown in
Fig 1A, human eosinophils exhibited immunoreactivity against the intracellular ligand-binding
regions of P2Y12R. The specificity of the polyclonal antibody for P2Y12R was corroborated by
complete neutralization of the immunostaining through preincubation of the anti-P2Y12R
polyclonal antibody with its respective specific blocking peptide immunogen. Furthermore, we
analyzed these P2Y12R-labeled eosinophils by fluorescence microscopy after DAPI (a nuclei
marker) addition (Fig 1B). Human eosinophils showed immunoreactivity against P2Y12R,
which suggests a cytoplasmic labeling. In fact, the expression of P2Y12R on isolated eosino-
philic granules has been demonstrated previously [12]. To investigate the functional roles of
the expression of P2Y12R on human eosinophils, we stimulated them with the nucleotide
ADP (0.1–100 nM), a classical ligand of P2Y12R. The eosinophils responded to ADP (100 nM)
(Fig 1C) by secreting granule-derived eosinophil peroxidade (EPO), indicating that the ex-
pression of P2Y12R on human eosinophils might have important functional roles in inducing
eosinophil protein release. To investigate whether the ADP-induced EPO secretion was re-
lated to P2Y12R or P2Y1R activation, the isolated eosinophils were pretreated with P2Y12R
(MRS2395) (10 μM) or P2Y1R (MRS2179) (10 μM) antagonists and then stimulated with ADP
(100 nM). P2Y1R is also sensitive to ADP, and its expression in human eosinophils is already
recognized [18]. As shown in Fig 1D, EPO secretion was significantly reduced in the presence
of the P2Y12R blocker, but no significant difference was observed when the cells were pre-
treated with the P2Y1R antagonist.
Fig 1. P2Y12R is expressed in human eosinophils andmediates ADP-induced eosinophil peroxidase
(EPO) secretion. Analysis of the expression of P2Y12R in human eosinophils by (A) flow cytometry and (B)
immunofluorescence. P2Y12R, green; nuclei, blue (after staining with DAPI). Shaded histogram represents
staining with control antibody (Ab). Dashed and solid lines represent staining with polyclonal antibodies
(pAbs) against P2Y12R and anti-P2Y12R pAbs neutralized by absorption with their immunogen peptide,
respectively. Data are from one experiment, representative of 3 experiments. (C) ADP-induced EPO
secretion after 1 h of stimulation is mediated by (D) P2Y12R. Graphs represent the mean ± SE (n = 3).
Results were analyzed by one-way ANOVA, followed by the Newman-Keuls test (+ and *p<0.05 for EPO
released compared with non-stimulated and ADP-stimulated eosinophils, respectively). NS = not stimulated,
OD = optical density.
doi:10.1371/journal.pone.0139805.g001
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P2Y12R blockade reduces the area of the hepatic inflammatory infiltrate
in a murine model of S.mansoni infection
The importance of the in vivomodulation of P2Y12R in the context of schistosomal inflamma-
tion was evaluated. We utilized a model of S.mansoni in mice, which causes a robust type 2
immune response. S.mansoni infection is known to promote a dramatic increase in liver fibro-
sis and in eosinophilopoesis, and in the number of eosinophils in the peripheral blood and
granulomas in host tissue [4]. To investigate the role of P2Y12R in tissue granulomatous
inflammatory reaction, we infected C57Bl/6 mice via the percutaneous route with 60 cercariae
and analyzed their livers 55 days after infection. The animals were treated with a P2Y12R
antagonist, clopidogrel (500 μg/mL) via the drinking water three days before and throughout
the infection period (55 days). To assess the bioavailability of clopidogrel given in the drinking
water, we performed a tail bleeding test based on the fact that clopidogrel is clinically used as
an antiplatelet drug [19] (S1 Fig). The eggs present in the liver were counted 55 days postinfec-
tion. Similar numbers of eggs were found in both clopidogrel-treated and non-treated mice
after liver (Fig 2A) and intestine (Fig 2B) analysis, thus indicating that the blockage of P2Y12R
did not interfere with the control of parasite oviposition. The presence of S.mansoni eggs in
the tissues triggered the formation of granulomas, characterized by the presence of macro-
phages, lymphocytes, and eosinophils [4]. Histopathological analysis of liver revealed that the
granuloma sizes in the livers were macroscopically reduced in clopidogrel-treated mice (Fig
3AI and 3AII). A quantitative analysis was performed and revealed a significant difference
between the treated and non-treated groups (Fig 3B). The number of eosinophils in the granu-
lomas of the clopidogrel-treated group was also significantly reduced compared to the control
group (Fig 4AI, 4AII and 4B). As found in human eosinophils, murine eosinophils from the
liver of S.mansoni-infected mice also expressed the P2Y12R (Fig 4C), as assessed by immuno-
fluorescence after analyzing Siglec-F and P2Y12R positive cells in cytospin smears. Using flow
cytometry studies, we verified that more than 90% of murine bone marrow derived eosinophils
express both Siglec-F and the P2Y12R (Fig 4D). Additionally, liver collagen content, as assessed
by hydroxyproline quantification, was reduced in clopidogrel-treated compared with non-
treated mice (Fig 5A). Similarly, the IL-4 and IL-13 cytokine levels, evaluated by ELISA in liver
Fig 2. P2Y12R blockade does not alter the course of S.mansoni parasite oviposition.Mice were infected with 60 S.mansoni cercariae through a
percutaneous route, and the livers and intestines were collected 55 days post-infection. Graphs show the number of eggs per gram tissue within (A) the liver
and (B) intestines. Data represents the mean ± SE; 5–8 infected mice were used as individual tissue donors and represents animals from at least 2
independent infection studies.
doi:10.1371/journal.pone.0139805.g002
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homogenates, were significantly reduced in the clopidogrel-treated group (Fig 5B and 5C),
likely reflecting an attenuated inflammatory cell migration to the hepatic tissue.
Th2 response to S.mansoni is not altered by P2Y12R blockade
Deficiency of Th2 polarization can inhibit eosinophilopoiesis and reduce the size of the granu-
loma on S.mansoni infection, which occurs in IL-5 or in concomitant IL-13/IL-4 deficiencies
[25, 26]. Therefore, we verified whether P2Y2R blockade could alter Th2 polarization and thus
impair eosinophil-dependent inflammation. S.mansoni infected, clopidogrel-treated mice
Fig 3. P2Y12R blockade reduces the area of the hepatic inflammatory infiltrate in a murinemodel of S.mansoni infection. Representative granuloma
images from infected mice (Ai) untreated or (Aii) treated with clopidogrel. Slide sections were stained with hematoxylin-eosin and examined under a light
microscope. (B) The individual granuloma area was estimated from 10–20 granulomas acquired for each individual mouse. Data represent the mean ± SE
and were analyzed by Student’s t test. (*p<0.05). n = 5–8 mice/group and represents animals from at least 2 independent infection studies.
doi:10.1371/journal.pone.0139805.g003
P2Y12R in Eosinophils and Anthelmintic Host Response
PLOS ONE | DOI:10.1371/journal.pone.0139805 October 8, 2015 9 / 21
P2Y12R in Eosinophils and Anthelmintic Host Response
PLOS ONE | DOI:10.1371/journal.pone.0139805 October 8, 2015 10 / 21
displayed a slight difference in the plasma concentrations of IL-13 (Fig 6A) but no difference in
the IL-4 levels (Fig 6B). Furthermore, when spleen cells were cultured with schistosomal egg
antigen (SEA) in vitro for 24 h and 48 h, the secreted levels of IL-13 were similar or slightly
greater in clopidogrel-treated mice compared with non-treated controls (data not shown).
P2Y12R blockade promotes an increase in blood eosinophilia but
decreases the eosinophil count in the bone marrow
S.mansoni infection causes robust eosinophilopoiesis and blood eosinophilia [8]. To investi-
gate whether blocking P2Y12R could interfere with these parameters, we performed blood
smears and a bone marrow count of clopidogrel-treated and untreated animals. Treatment
with a P2Y12R blocker increased the number of eosinophils in the blood (Fig 7A), whereas it
reduced eosinophil numbers in the bone marrow (Fig 7B). No changes were observed for
mononuclear cells or neutrophils. These results might suggest that blocking P2Y12R may influ-
ence the recruitment of eosinophils in the bone marrow into the blood or impair the migration
of these cells into the infected tissues.
ADP does not act as a chemotactic for human eosinophils and neither
induces or prevents their survival
Because liver granulomas from S.mansoni-infected, clopidogrel-treated mice had fewer eosino-
phils compared with those from untreated mice, we investigated whether ADP could also be a
chemoattractant for eosinophils or prevent eosinophil apoptosis. It has been reported that
nucleotides such as ATP and ADP at high, non-physiological concentrations have a chemoat-
tractant effect on neutrophils, eosinophils and macrophages [15, 18, 27, 28]. Human isolated
eosinophils were submitted to a transwell assay against eotaxin (20 ng/ml), a known eosinophil
chemoattractant (used here as a positive control), and ADP (100 and 10 nM). Eotaxin attracted
large numbers of eosinophils (43.9%) compared to non-stimulated conditions (medium)
(5.7%)(Fig 8A). However, ADP at concentrations capable of inducing EPO secretion (100 and
10 nM) failed to promote eosinophil chemotaxis (5.8% and 4.9%, respectively) compared to
medium (5.7%)(Fig 8A). To evaluate whether P2Y12R might be required for optimal IL-
5-induced chemokinetic responses, eosinophils were primed with IL-5 for 1 h. It is known that
IL-5 priming induces random, chemokinetic migration of eosinophils [29] and enhances eosin-
ophil chemotactic responses to subsequent stimulation (i.e., with IL-8 or leukotriene B4
[LTB4]) in vitro [29]. As shown in Fig 8B, ADP (100 and 10 nM) did not interfere with eosino-
phil migration after IL-5 priming (50% and 50.1%, respectively) compared to the condition
without ADP (IL-5 + medium) (52.2%). Eotaxin (used here as a positive control) showed
enhanced eosinophil chemoattractant properties (75.3%) compared to just IL-5 priming (IL-5
+ medium) (52.2%) (Fig 8B) or eotaxin alone (43.9%). Next, we investigated whether P2Y12R
might be involved in chemotaxis induced by eotaxin, as previously mentioned, a known physi-
ologic eosinophil chemoattractant. As shown in Fig 8C, the compound MRS2395 10 μM (a
P2Y12R blocker) failed to impair eotaxin-induced eosinophil recruitment (59.6%) compared
to the control (eotaxin + vehicle) (62.3%). To assess a possible anti-apoptotic effect for ADP in
Fig 4. P2Y12R blockade impairs hepatic granulomatous eosinophilia. Representative granuloma images from infected mice (Ai) untreated or (Aii)
treated with clopidogrel. Slide sections were stained with Syrius red (modified method) and examined under a light microscope. (B) The number of
eosinophils per granuloma area were calculated from images of 10–20 granulomas acquired for each individual mouse. Data represent the mean ± SE and
were analyzed by Student’s t test. (*p<0.05). n = 10 mice/group and represents animals from at least 2 independent infection studies. (C)
Immunofluorescence showing Siglec-F and P2Y12R staining of cytospin smears of murine eosinophil-enriched suspensions. P2Y12R, green; Siglec-F, red;
Ab = antibody. Data are from one experiment, representative of 3 experiments. (D) Flow cytometry dot plots showing isotype control (left panel) and Siglec-F
versus P2Y12R staining (right panel) of mice bone marrow derived eosinophils. Data are from one experiment, representative of 3 experiments.
doi:10.1371/journal.pone.0139805.g004
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human eosinophils, the cells were cultured 24 h with ADP (100 and 10 nM), labeled with
annexin V and immediately evaluated by flow cytometry. No difference in eosinophil apoptosis
was observed when the cells were cultured with 100 nM (Fig 9C) or 10 nM ADP (Fig 9D) com-
pared with the control conditions (Fig 9A). Eosinophils cultured for 24 h with IL-5 were used
as a positive control (Fig 9B). This result suggests that P2Y12R does not interfere with the apo-
ptosis of human eosinophils. The compound MRS2395 (10 μM), a P2Y12R antagonist, does
not have apoptotic effects itself (Fig 9F) compared to its diluent (DMSO) (Fig 9E).
Discussion
Identifying new target molecules that account for eosinophil activation may be highly impor-
tant for our understanding of the pathophysiology of host immune responses to parasites, aller-
gic inflammation and related eosinophilic diseases. We have recently reported the expression
of P2Y12R on human eosinophils and isolated human eosinophil granules [12]. In the present
study, we demonstrated that isolated human eosinophils secrete EPO in response to ADP in a
mechanism dependent on P2Y12R. In vivo, we found that P2Y12R blockade reduces the
hepatic granulomatous inflammatory response in S.mansoni infection without affecting the
Th2 response. P2Y12R blockade modulated hepatic tissue inflammation but did not impair S.
mansoni egg oviposition, indicating that the blockage of P2Y12R does not affect the infection
regarding parasite load. In this regard, clopidogrel-treated mice had reduced granuloma areas
with less eosinophils during S.mansoni infection. However, the plasma levels of IL-13 and IL-
4, as well as the levels of IL-13 produced by splenocytes in response to SEA, were not impor-
tantly affected by P2Y12R blockage, indicating that P2Y12R is not essential to Th2 polariza-
tion. As found for humans, murine eosinophils also express the P2Y12R. Because liver
granulomas from S.mansoni-infected, clopidogrel-treated mice had fewer eosinophils
Fig 5. P2Y12R blockade reduces fibrosis and Th2 cytokine production in liver homogenates. (A) Liver
collagen content, as assessed by hydroxyproline quantification, (B) IL-4 and (C) IL-13 were reduced in
clopidogrel-treated mice compared to the untreated mice. Data represent the mean ± SE and were analyzed
by Student’s t test. (*p<0.05). n = 5–8 mice/group and represents animals from at least 2 independent
infection studies. Dashed line–hydroxyproline levels in uninfected mice.
doi:10.1371/journal.pone.0139805.g005
Fig 6. Th2 response to S.manoni infection is not altered by P2Y12R blockade. S.mansoni-infected, clopidogrel-treated mice displayed a slight
difference in plasma concentrations of (A) IL-13, but no difference in (B) IL-4 levels was detected. Data represent the mean ± SE and were analyzed by
Student’s t test. (*p<0.05). n = 5–8 mice/group and represents animals from at least 2 independent infection studies.
doi:10.1371/journal.pone.0139805.g006
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compared with those from untreated mice, we tested whether ADP could also be a chemoat-
tractant to eosinophils or prevent eosinophil apoptosis. We found that this is unlikely based on
our results in vitro, in which ADP did not interfere with eosinophil chemotaxis or survival.
Our results demonstrate a previously unrecognized role for P2Y12R in as a modulator of eosin-
ophil activation and in schistosomal inflammation.
Using flow cytometry and immunofluorescence techniques, our results confirmed previous
findings that demonstrate that peripheral human eosinophils express P2Y12R. Notably, immu-
nofluorescence microscopy images indicate an intracellular clustered labeling for P2Y12R. In
fact, our group previously described P2Y12R expression in intact, non-permeabilized eosino-
phils and on the membranes of intracellular eosinophil granules [12]. Functionally, our results
show that P2Y12R is involved in EPO secretion by eosinophils. Data from the literature indi-
cate that other cationic proteins, such as ECP, and cytokines such as IL-8 are secreted in
response to ATP, UTP and UDP, but not ADP [30]. Notably, in this study, the cells were stim-
ulated with nucleotides at micromolar concentrations, contrasting with the nanomolar range
used in our experiments. Studies suggest that eosinophils can cause parasite harm in S.mansoni
and other worm infections in vitro [5] and in vivo [6]. Nevertheless, mice that are selectively
deficient in eosinophils [9] or IL-5 [25] control parasite burden as efficiently as wild-type mice.
In agreement with these data, we showed here that S.mansoni infection in clopidogrel-treated
mice is efficiently controlled concerning the parasite load, despite the reduced numbers of
eosinophils. In our findings we noticed a prominent reduction in the area size of granulomas
possible due to the reduction of infiltrating inflammatory cells. Despite we identified less eosin-
ophils in the granulomas and found that mouse eosinophils also express the P2Y12R, whether
they or other cells are responsible to the observations related to granuloma size is not possible
to define. In addition, if mouse eosinophils are capable to secrete cationic proteins in vivo via
the P2Y12R activation and contribute to the inflammatory host response is still not known.
The granuloma formation around eggs also depends on Th2 responses, as demonstrated in IL-
4/IL-13- [26], IL-10/IL-4- [31], and IL-4αR-deficient mice [32], in which the development of
Fig 7. P2Y12R blockade promotes an increase in blood eosinophilia but decreases the eosinophil count in the bonemarrow. (A) The number of
eosinophils was estimated in the blood of infected, clopidogrel-untreated and clopidogrel-treated mice (Panoptic kit-stained smears). (B) The number of
eosinophils in the individual bone marrow was evaluated in clopidogrel-untreated and -treated mice (Panoptic kit-stained cytospins). Data represent the
mean ± SE and were analyzed by Student’s t test. (*p<0.05). n = 5–8 mice/group and represent animals from at least 2 independent infection studies.
doi:10.1371/journal.pone.0139805.g007
P2Y12R in Eosinophils and Anthelmintic Host Response
PLOS ONE | DOI:10.1371/journal.pone.0139805 October 8, 2015 14 / 21
Th2-polarized responses to eggs leads to abnormal granulomas and liver injury. The reduction
in the area size of the liver granulomas in S.mansoni-infected, clopidogrel-treated mice does
not seem to be the consequence of a weakened Th2 response because infected clopidogrel-
treated mice do not have strongly reduced plasma concentrations of IL-4 and IL-13 and do not
have lower levels of IL-13 production by spleen cells in response to SEA. These results indicate
that the control exerted by the P2Y12R blockade on the area size of egg granulomas is likely
not related to a disorder of the Th2 response.
The production of IL-13 [26] and tissue eosinophilia have been thought to participate in the
fibrosis and resultant portal hypertension that causes morbidity during the chronic phase of
the infection. Our results of collagen deposition in S.mansoni-infected mice showed that
P2Y12R blockade is relevant for liver fibrosis induced by Th2 inflammation. One hypothesis is
that the reduced inflammatory cells infiltration might be contributing to the impaired collagen
Fig 8. ADP is not chemotactic for human eosinophils. Human eosinophil-enriched suspensions containing 3x105 cells/100 μL were left to migrate in
transwell plates against eotaxin (20 ng/mL) (positive control) or ADP (100 and 10 nM) in (A) the absence or (B) presence of IL-5 (30 ng/mL) for 3 h at 37°C.
(C) MRS2395 (10 μM), a P2Y12R antagonist, failed to inhibit the eotaxin-induced eosinophil recruitment. Data are representative dot plots (SSC-A/FSC-A) of
3 independent experiments (n = 3). Vehicle = MRS2395 diluent (DMSO).
doi:10.1371/journal.pone.0139805.g008
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deposition in clopidogrel-treated mice compared with the non-treated group. The role of
eosinophils in promoting fibrosis and collagen deposition remains controversial. Although a
previous study demonstrated an essential role for eosinophils on the collagen deposition and
tissue remodeling induced by OVA immunization and challenge using eosinophil-ablated mice
[33], a collagen deposition similar to wild-type controls was found in the livers of these eosino-
phil deficient mice when they were infected with S.mansoni [9]. Because several studies have
confirmed that the production of IL-13, in contrast, is a principal factor inducing fibrosis [25,
26], we believe that the impaired hepatic and plasma levels of IL-13 that we found in clopido-
grel-treated compared to clopidogrel-untreated mice can account for their diminished collagen
deposition.
The reduced granuloma sizes at S.mansoni-infected sites might be associated with impaired
leukocyte transmigration from the vascular compartment. S.mansoni infection causes robust
eosinophilopoiesis and blood eosinophilia [8]. In this regard, the analysis of blood and bone
marrow eosinophilia in clopidogrel-treated mice revealed that P2Y12R blockade promoted an
increase in blood eosinophilia but decreased the eosinophil count in the bone marrow. No
changes were observed for mononuclear cells or neutrophils. These results might suggest that
blocking P2Y12R may influence the recruitment of eosinophils from the bone marrow to the
blood or impair the migration of these cells to the infected tissues. There is no evidence in the
literature that correlates P2Y12R and modulation of adhesion molecule expression or eosino-
poiesis. However, the expression and the role of P2Y12R in platelets as therapeutic targets for
antiplatelet agents is widely known [34]. Beyond their primary role in hemostasis, platelets are
causally involved in the onset of inflammatory reactions, cell proliferation and the immune
response [35]. Platelet activation and platelet binding to the endothelium result in the release
of chemokines and the increased expression of adhesion molecules, which promote the recruit-
ment of leukocytes that will eventually migrate across the endothelium into the tissue [35].
Thus, a reduction in eosinophil transmigration might be a consequence of the impairment of
platelet aggregation in clopidogrel-treated mice. Furthermore, through their ability to interact
with other cells, platelets are involved in many physiological and pathological processes in
addition to vascular inflammation, including eosinophilic disorders such as allergic asthma
[36, 37]. Platelets are necessary for lung leukocyte recruitment in a murine model of allergic
inflammation [38]. In addition, platelets and P2Y12R has been reported to be required for the
inflammatory activities of the stable abundant mediator LTE4 in asthma and has been sug-
gested to be a potential therapeutic target for this disease because clopidogrel showed efficacy
in the treatment of experimental allergen-induced pulmonary inflammation [20]. Although
not fully elucidated, the mechanism suggested for the role of P2Y12R in this process was its
association with an as yet not identified coreceptor of the cysteinyl leukotriene family. Whether
platelets or their activation via the P2Y12R are important for the inflammatory host responses
to S.mansoni is still unknown. P2Y12R may also be expressed in other cells of the immune sys-
tem involved in the inflammatory host responses to S.mansoni. High amounts of P2Y12R
mRNA have been found previously in both lymphocytes and CD34+ progenitor cells [39]. In
addition, a varied range of purinergic receptors is expressed in dendritic cells and plays roles in
their maturation and the coordination of the immune response [40]. In these cells, ADP stimu-
lates calcium mobilization and ERK phosphorylation in a pertussis toxin-dependent manner as
well as inhibits IL-12 production [40]. However, it is important to notice that the use of
Fig 9. ADP did not induce/prevent eosinophil apoptosis. Human eosinophils were cultured for 24 h in the presence of IL-5 (30 ng/mL) or ADP (100 and
10 nM) or MRS2395 (10 μM), followed by labeling with annexin V and flow cytometry analysis. Data are representative histograms of 3 independent
experiments (n = 3). Vehicle = MRS2395 diluent (DMSO).
doi:10.1371/journal.pone.0139805.g009
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clopidogrel in millions of patients with ischemic diseases over the years has not yet been stated
to cause the development of selective immune disorders related to the drug. Similarly, patients
deficient in the P2Y12R do not suffer from explicit disorders of their immune system [36].
Because we demonstrated that P2Y12R is important for modulating the schistosomal
inflammatory response and tissue eosinophilia, we wondered whether ADP would be capable
of attracting human eosinophils in transwell assays as well as acting as a survival factor for
these cells. ADP selectively activates the receptors for P2Y1, P2Y12 and P2Y13. ADP is known
to activate P2Y1R, P2Y12R and P2Y13R, with EC50 values of 8 μM, 0.07 μM and 0.06 μM,
respectively [41]. Human eosinophils are recognized to express P2Y1R and P2Y12R [18]. Thus
far, there is no evidence of the expression of P2Y13R in human eosinophils. Thus, the use of
ADP at nanomolar concentrations in our experiments might be expected to selectively act on
P2Y12R. Nucleotides belong to the group of constitutive DAMPs that are released as a conse-
quence of cellular damage during the course of infection or in sterile inflammation [42].
Because of its small size and high mobility, ATP can be fast released together with other cellular
components after cell injury, mechanical stress or cell death [42]. Augmented ATP concentra-
tion in the extracellular milieu is thus closely associated with tissue stress or damage [42]. How-
ever, nonlytic nucleotide release may happen in different cell types under a diversity of
conditions. ATP is found at relatively high levels in the cytoplasm of cells, where its concentra-
tion ranges from 1 to 10 mM. In the extracellular space, its physiologic concentration is signifi-
cantly lower, ranging between 1 and 10 nM [43]. Once released extracellularly, ATP is rapid
converted to ADP, AMP and adenosine by cell membrane-expressed ectonucleotidases [43]. In
our studies, ADP at concentrations capable of inducing eosinophil EPO secretion did not pro-
mote or prevent eosinophil apoptosis. There is no evidence in the literature concerning the
effect of nucleotides or purinergic receptors on eosinophil survival. Furthermore, ADP at con-
centrations capable of inducing eosinophil EPO secretion was not chemotactic for human
eosinophils. Different studies suggest that nucleotides such as ATP and ADP are chemotactic
for eosinophils [44–46] and other cell types [27, 47]. Burgers and colleagues suggest that ATP
secreted by platelets activated by thrombin activates and is chemotactic for human eosinophils
[44]. These studies were followed by others in which ADP, ATP and other nucleotides were
shown to be capable of inducing eosinophil chemotaxis, ROS production and CD11b expres-
sion [17, 18, 45, 48]. However, in all of these studies, the concentrations of ADP used were at
micromolar concentrations or higher, which might be considered a supraphysiological range.
Our concern is whether the utilization of abnormal nucleotide concentrations might alter the
physiological conditions, resulting in artificial responses and in the loss of ADP specificity in
purinergic receptors. In fact, different studies describe the chemotactic effects of ATP, ADP
and other nucleotides in different immune cells, including neutrophils, mast cells, lympho-
cytes, dendritic cells and macrophages [17]. However, in all of these studies, the concentrations
of nucleotides utilized were at a higher range than we used in our studies.
IL-5 priming induces the random, chemokinetic migration of eosinophils [29] and enhances
eosinophil chemotactic responses to subsequent stimulation (i.e., with IL-8 or leukotriene B4)
in vitro. However, even after IL-5 priming, ADP (100 and 10 nM) was not capable of promot-
ing human eosinophil chemotaxis. We also verified possible autocrine/paracrine roles of
P2Y12R in the chemotaxis induced by known eosinophil physiological activators such as
eotaxin. A study published by Kronlage and colleagues revealed that C5a-induced macrophage
chemotaxis is dependent on the paracrine/autocrine activation of the P2Y12 and P2Y2 recep-
tors [27]. Additionally, Isford and colleagues described that the activation of these receptors is
important for macrophage chemokinesis, but not chemotaxis, contrasting the data that show
that nucleotides work as a “find me” signal for macrophages, directing them toward inflamed
sites [49]. In our experiments, P2Y12R antagonists failed to block eotaxin-induced eosinophil
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migration, suggesting that this receptor is not likely involved in the chemotactic response
induced by this chemokine.
In conclusion, our studies demonstrate that P2Y12R modulation plays a role in eosinophil
biology and in the host response to schistosomal infection. The reduced granulomatous area in
clopidogrel-treated mice during S.mansoni infection occurred irrespective of robust alterations
in the antigen-driven immune response, thus indicating that the response mediated by this
receptor is downstream of these events. Our data also implicate P2Y12R as a mediator for
ADP-induced EPO secretion in human eosinophils, but not for eosinophil chemotaxis or sur-
vival. Together, these results demonstrate a formerly unrecognized role for P2Y12R in eosino-
phil activation and schistosomal inflammation.
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